Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
23535 | 343 | 33.8 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
389 | 3 | PEROXISOME//CARNITINE//JOURNAL OF INHERITED METABOLIC DISEASE | 30841 |
3076 | 2 | PEPTIDE DEFORMYLASE//ENOYL ACP REDUCTASE//ACYL CARRIER PROTEIN | 2395 |
23535 | 1 | PEPTIDE DEFORMYLASE//PEPTIDE DEFORMYLASE INHIBITORS//DEFORMYLASE | 343 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PEPTIDE DEFORMYLASE | authKW | 4424973 | 19% | 76% | 65 |
2 | PEPTIDE DEFORMYLASE INHIBITORS | authKW | 769415 | 3% | 79% | 11 |
3 | DEFORMYLASE | authKW | 569749 | 2% | 80% | 8 |
4 | ACTINONIN | authKW | 562844 | 4% | 45% | 14 |
5 | INFECT DIS THER EUT AREA | address | 457835 | 2% | 86% | 6 |
6 | HUMAN PEPTIDE DEFORMYLASE | authKW | 445119 | 1% | 100% | 5 |
7 | PEPTIDE DEFORMYLASE PDF | authKW | 370931 | 1% | 83% | 5 |
8 | PROMEDITECH LTD | address | 356095 | 1% | 100% | 4 |
9 | PDF INHIBITOR | authKW | 284874 | 1% | 80% | 4 |
10 | FUMIMYCIN | authKW | 267071 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 1216 | 18% | 0% | 62 |
2 | Microbiology | 795 | 21% | 0% | 72 |
3 | Biochemistry & Molecular Biology | 584 | 36% | 0% | 124 |
4 | Pharmacology & Pharmacy | 406 | 22% | 0% | 75 |
5 | Biophysics | 304 | 12% | 0% | 40 |
6 | Chemistry, Organic | 296 | 15% | 0% | 50 |
7 | Biochemical Research Methods | 84 | 6% | 0% | 21 |
8 | Information Science & Library Science | 79 | 3% | 0% | 9 |
9 | Infectious Diseases | 68 | 5% | 0% | 17 |
10 | Architecture | 44 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INFECT DIS THER EUT AREA | 457835 | 2% | 86% | 6 |
2 | PROMEDITECH LTD | 356095 | 1% | 100% | 4 |
3 | ANTIBACTERIAL DISCOVERY PERFORMANCE UNIT | 198271 | 2% | 32% | 7 |
4 | PRBMH | 178047 | 1% | 100% | 2 |
5 | UPR40 | 142433 | 1% | 40% | 4 |
6 | CRISTALLOG RMN BIOL PHARM | 118697 | 1% | 67% | 2 |
7 | UPR2355 | 101146 | 3% | 11% | 10 |
8 | AGR SCI N N323 | 89024 | 0% | 100% | 1 |
9 | AGR SCI N N32D | 89024 | 0% | 100% | 1 |
10 | BIOPHYS PROGRAM PROT GRP | 89024 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 4862 | 10% | 0% | 36 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3375 | 9% | 0% | 31 |
3 | SCIENTIST | 2957 | 3% | 0% | 9 |
4 | ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY | 719 | 2% | 0% | 6 |
5 | JOURNAL OF ASIAN ARCHITECTURE AND BUILDING ENGINEERING | 662 | 1% | 0% | 2 |
6 | JOURNAL OF MOLECULAR BIOLOGY | 627 | 4% | 0% | 13 |
7 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 564 | 3% | 0% | 9 |
8 | MEDICINAL CHEMISTRY RESEARCH | 442 | 1% | 0% | 4 |
9 | ANNUAL REPORTS IN MEDICINAL CHEMISTRY | 397 | 1% | 0% | 2 |
10 | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT | 377 | 0% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEPTIDE DEFORMYLASE | 4424973 | 19% | 76% | 65 | Search PEPTIDE+DEFORMYLASE | Search PEPTIDE+DEFORMYLASE |
2 | PEPTIDE DEFORMYLASE INHIBITORS | 769415 | 3% | 79% | 11 | Search PEPTIDE+DEFORMYLASE+INHIBITORS | Search PEPTIDE+DEFORMYLASE+INHIBITORS |
3 | DEFORMYLASE | 569749 | 2% | 80% | 8 | Search DEFORMYLASE | Search DEFORMYLASE |
4 | ACTINONIN | 562844 | 4% | 45% | 14 | Search ACTINONIN | Search ACTINONIN |
5 | HUMAN PEPTIDE DEFORMYLASE | 445119 | 1% | 100% | 5 | Search HUMAN+PEPTIDE+DEFORMYLASE | Search HUMAN+PEPTIDE+DEFORMYLASE |
6 | PEPTIDE DEFORMYLASE PDF | 370931 | 1% | 83% | 5 | Search PEPTIDE+DEFORMYLASE+PDF | Search PEPTIDE+DEFORMYLASE+PDF |
7 | PDF INHIBITOR | 284874 | 1% | 80% | 4 | Search PDF+INHIBITOR | Search PDF+INHIBITOR |
8 | FUMIMYCIN | 267071 | 1% | 100% | 3 | Search FUMIMYCIN | Search FUMIMYCIN |
9 | PDF INHIBITION | 267071 | 1% | 100% | 3 | Search PDF+INHIBITION | Search PDF+INHIBITION |
10 | BB 83698 | 178047 | 1% | 100% | 2 | Search BB+83698 | Search BB+83698 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JAIN, R , CHEN, D , WHITE, RJ , PATEL, DV , YUAN, Z , (2005) BACTERIAL PEPTIDE DEFORMYLASE INHIBITORS: A NEW CLASS OF ANTIBACTERIAL AGENTS.CURRENT MEDICINAL CHEMISTRY. VOL. 12. ISSUE 14. P. 1607-1621 | 65 | 96% | 78 |
2 | SHARMA, A , KHULLER, GK , SHARMA, S , (2009) PEPTIDE DEFORMYLASE - A PROMISING THERAPEUTIC TARGET FOR TUBERCULOSIS AND ANTIBACTERIAL DRUG DISCOVERY.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 13. ISSUE 7. P. 753-765 | 66 | 70% | 16 |
3 | FIEULAINE, S , DE SOUSA, RA , MAIGRE, L , HAMICHE, K , ALIMI, M , BOLLA, JM , TALEB, A , DENIS, A , PAGES, JM , ARTAUD, I , ET AL (2016) A UNIQUE PEPTIDE DEFORMYLASE PLATFORM TO RATIONALLY DESIGN AND CHALLENGE NOVEL ACTIVE COMPOUNDS.SCIENTIFIC REPORTS. VOL. 6. ISSUE . P. - | 57 | 69% | 0 |
4 | SANGSHETTI, JN , KHAN, FAK , SHINDE, DB , (2015) PEPTIDE DEFORMYLASE: A NEW TARGET IN ANTIBACTERIAL, ANTIMALARIAL AND ANTICANCER DRUG DISCOVERY.CURRENT MEDICINAL CHEMISTRY. VOL. 22. ISSUE 2. P. 214 -236 | 45 | 74% | 9 |
5 | CHEN, D , YUAN, Z , (2005) THERAPEUTIC POTENTIAL OF PEPTIDE DEFORMYLASE INHIBITORS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 14. ISSUE 9. P. 1107-1116 | 44 | 92% | 24 |
6 | YUAN, ZY , WHITE, RJ , (2006) THE EVOLUTION OF PEPTIDE DEFORMYLASE AS A TARGET: CONTRIBUTION OF BIOCHEMISTRY, GENETICS AND GENOMICS.BIOCHEMICAL PHARMACOLOGY. VOL. 71. ISSUE 7. P. 1042-1047 | 38 | 90% | 30 |
7 | LIN, PH , HU, TC , HU, JA , YU, WQ , HAN, C , ZHANG, JA , QIN, GR , YU, KQ , GOTZ, F , SHEN, X , ET AL (2010) CHARACTERIZATION OF PEPTIDE DEFORMYLASE HOMOLOGUES FROM STAPHYLOCOCCUS EPIDERMIDIS.MICROBIOLOGY-SGM. VOL. 156. ISSUE . P. 3194-3202 | 37 | 79% | 0 |
8 | MIN, S , INGRAHAM, K , HUANG, JZ , MCCLOSKEY, L , TILLING, S , WINDAU, A , PIZZOLLO, J , BUTLER, D , AUBART, K , MILLER, LA , ET AL (2015) FREQUENCY OF SPONTANEOUS RESISTANCE TO PEPTIDE DEFORMYLASE INHIBITOR GSK1322322 IN HAEMOPHILUS INFLUENZAE, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PYOGENES, AND STREPTOCOCCUS PNEUMONIAE.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 59. ISSUE 8. P. 4644 -4652 | 26 | 93% | 1 |
9 | YUAN, ZY , TRIAS, J , WHITE, RJ , (2001) DEFORMYLASE AS A NOVEL ANTIBACTERIAL TARGET.DRUG DISCOVERY TODAY. VOL. 6. ISSUE 18. P. 954 -961 | 35 | 85% | 85 |
10 | MOLTENI, V , KREUSCH, A , (2005) PEPTIDE DEFORMYLASE INHIBITORS: A SURVEY OF THE PATENT LITERATURE.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 15. ISSUE 10. P. 1423-1437 | 45 | 63% | 0 |
Classes with closest relation at Level 1 |